JP2024542126A5 - - Google Patents

Info

Publication number
JP2024542126A5
JP2024542126A5 JP2024526788A JP2024526788A JP2024542126A5 JP 2024542126 A5 JP2024542126 A5 JP 2024542126A5 JP 2024526788 A JP2024526788 A JP 2024526788A JP 2024526788 A JP2024526788 A JP 2024526788A JP 2024542126 A5 JP2024542126 A5 JP 2024542126A5
Authority
JP
Japan
Prior art keywords
nucleic acid
sequence
optionally
acid sequence
coding nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024526788A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024542126A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/079505 external-priority patent/WO2023081935A2/en
Publication of JP2024542126A publication Critical patent/JP2024542126A/ja
Publication of JP2024542126A5 publication Critical patent/JP2024542126A5/ja
Pending legal-status Critical Current

Links

JP2024526788A 2021-11-08 2022-11-08 自己増幅rna組成物及びその使用方法 Pending JP2024542126A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163277116P 2021-11-08 2021-11-08
US63/277,116 2021-11-08
PCT/US2022/079505 WO2023081935A2 (en) 2021-11-08 2022-11-08 Self-amplifying rna compositions and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024542126A JP2024542126A (ja) 2024-11-13
JP2024542126A5 true JP2024542126A5 (https=) 2025-11-17

Family

ID=86242092

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024526788A Pending JP2024542126A (ja) 2021-11-08 2022-11-08 自己増幅rna組成物及びその使用方法

Country Status (9)

Country Link
US (1) US20250108105A1 (https=)
EP (1) EP4430200A4 (https=)
JP (1) JP2024542126A (https=)
KR (1) KR20240099240A (https=)
CN (1) CN118382701A (https=)
AU (1) AU2022380858A1 (https=)
CA (1) CA3236959A1 (https=)
IL (1) IL312557A (https=)
WO (1) WO2023081935A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022380858A1 (en) * 2021-11-08 2024-05-30 Seattle Project Corp. Self-amplifying rna compositions and methods of use thereof
CN120082547B (zh) * 2025-05-06 2025-10-03 北京悦康科创医药科技股份有限公司 用于自复制mRNA的加帽类似物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109045294A (zh) * 2013-01-10 2018-12-21 思齐乐 流感病毒免疫原性组合物及其应用
SI3445850T1 (sl) * 2016-04-22 2021-12-31 BioNTech SE Postopki za zagotavljanje enoverižne RNA
BE1024796B9 (fr) * 2016-06-02 2019-01-08 Glaxosmithkline Biologicals Sa Constructions antigeniques du virus zika
CA3173803A1 (en) * 2020-04-21 2021-10-28 Karin Jooss Capping compounds, compositions and methods of use thereof
AU2022380858A1 (en) * 2021-11-08 2024-05-30 Seattle Project Corp. Self-amplifying rna compositions and methods of use thereof

Similar Documents

Publication Publication Date Title
US12397048B2 (en) Bunyavirales vaccine
JP2021525076A5 (https=)
JP7613685B2 (ja) 新規rsv rna分子及びワクチン接種用組成物
EP3548625B1 (en) Compositions and methods for enhancing gene expression
JP2023523414A5 (https=)
JP2023526495A5 (https=)
WO2020002525A1 (en) Novel lassa virus rna molecules and compositions for vaccination
Maruggi et al. Self-amplifying mRNA-based vaccine technology and its mode of action
JP2022512912A5 (https=)
JP2023541108A5 (https=)
EP4289956A1 (en) Cis-replicon construct
EP3773702A2 (en) Novel yellow fever nucleic acid molecules for vaccination
JP2022539417A5 (https=)
JP2024528447A (ja) 非天然型5’非翻訳領域及び3’非翻訳領域、及びその用途
JP2024542126A5 (https=)
TW202108598A (zh) 用作b型肝炎病毒(hbv)疫苗之自我複製rna分子及其用途
JP2023521662A5 (https=)
JP2023523413A5 (https=)
CN106459997A (zh) 用于疫苗应用的高效价病毒样囊泡的进化
CN118556131A (zh) 用于蛋白质表达的mRNA及其模板
WO2022133230A1 (en) Combination therapy for treating hepatitis b virus infection
KR20240099240A (ko) 자가 증폭 rna 조성물 및 이의 사용 방법
CN120888569A (zh) 一种自复制mRNA疫苗及其制备方法和用途
JP2025501772A (ja) コロナウイルスワクチン
JP2023553014A5 (https=)